Wesfarmers has released its first half year financial results for 2025-26, with the Wesfarmers Health division recording an 8.4% increase in revenue and 35.7% increase in earnings.
Priceline Pharmacy posted a 14.4% increase in sales, including dispensary sales, underpinned by network expansion, promotional campaigns and differentiated personal care products.
MediAesthetics also delivered profitable growth, while the growth in InstantScripts services ensured digital health maintained strong momentum.
In terms of outlook, the report to shareholders noted that “Wesfarmers Health is well-positioned to improve long-term earnings and returns by executing its transformation program and capitalising on favourable structural trends in health and beauty.”
More details in today’s issue of Pharmacy Daily.
